In vitro skin irritation testing has emerged as a critical component in the safety evaluation of chemicals and medical devices, aiming to replace traditional animal-based assays. Central to this ...

Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.

Developing new topical drugs or cosmetics requires a long, expensive research and marketing process, with each launch estimated to cost about $3 billion. With a growing demand to replace animal ...

Infectious complications are not uncommon after implant placement. The risk is higher in heavily contaminated wounds, which ...

Expanding RPM to more health areas connects patients more seamlessly to healthcare professionals in between visits.

There are a number of considerations that can help streamline the pathway to the clinic. One of the first is which vector system will be used, with AAV and lentivirus being two of the most commonly ...

The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.

Non-Alcoholic Fatty Liver Disease (NAFLD) Affects 30-40% of U.S. Adults, Driving Significant Market Need for BioHarvest's Future Olive Cell Product Targeting Liver Health Vancouver, British Columbia ...

Ortho Clinical Diagnostics is hoping to pay down a large portion of its debts by riding a wave of COVID-19 and broader in vitro lab testing demands to a $1.5 billion IPO. The company is offering 70 ...

Addressing for the first time the issue of whether bioequivalence data and in vitro testing can show that an abbreviated new drug application (ANDA) product with different immediate and delayed ...

FOR BIOTECH, DEB, IT REALLY IS. IN THE PAST LEGISLATIVE SESSION, MARYLAND’S GENERAL ASSEMBLY PASSED A BILL PROVIDING GRANTS TO MARYLAND SCIENTISTS WHO DEVELOP NON ANIMAL BASED RESEARCH METHODS. IT WAS ...